Characterization of neutralizing antibodies to West Nile virus (Q40509400)

21 September 2017

Characterization of neutralizing antibodies to West Nile virus (English)

1 reference

21 September 2017

0 references

1 reference

2

Theodore C Pierson

1 reference

21 September 2017

4

Sheri L Hanna

1 reference

21 September 2017

9

Robert W Doms

1 reference

21 September 2017

Melissa D Sánchez

1

1 reference

21 September 2017

Douglas McAllister

3

1 reference

21 September 2017

Bridget A Puffer

5

1 reference

21 September 2017

Laura E Valentine

6

1 reference

21 September 2017

Mariam M Murtadha

7

1 reference

21 September 2017

James A Hoxie

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

21 September 2017

1 reference

21 September 2017

336

1 reference

21 September 2017

1

1 reference

21 September 2017

70-82

1 reference

Glycosylation and antigenic variation among Kunjin virus isolates

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Human immunoglobulin as a treatment for West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Current status of flavivirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Antigenic analysis of West Nile virus strains using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

A new mechanism for the neutralization of enveloped viruses by antiviral antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Monoclonal antibodies to Kunjin and Kokobera viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structures and mechanisms in flavivirus fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Occupancy and mechanism in antibody-mediated neutralization of animal viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Comparative analysis of west nile virus strains isolated from human and animal hosts using monoclonal antibodies and cDNA restriction digest profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

A ligand-binding pocket in the dengue virus envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structure of the dengue virus envelope protein after membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structure of West Nile Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Vaccines and animal models for arboviral encephalitides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Monoclonal antibodies against the flavivirus West Nile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Antigenic structure of flavivirus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

RASMOL: biomolecular graphics for all

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Immunization of mice against West Nile virus with recombinant envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

An infectious clone of the West Nile flavivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Structures of immature flavivirus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.02.020

1 reference

21 September 2017

1 reference